"Magic mushrooms" are becoming more popular in the cultural and political spheres. However, the psychedelic ingredient, psilocybin, is still classified as a Schedule 1 substance in the US. With thousands of medical studies demonstrating how psilocybin leads to improved mental health, this once-taboo substance has been approved for legal treatment in Oregon and decriminalization in Washington state.
In the wellness space, many early investors and innovators are getting in line, with a waiting list of consumers ready for a psilocybin market.
The latest Evergi report explores: